Name | Neuropeptide Y (29-64), amide, human acetate |
Description | Neuropeptide Y (29-64), amide, human acetate is involved in Alzheimer's disease (AD) and protects rat cortical neurons against β-Amyloid toxicity. |
In vitro | It is showed that Neuropeptide Y (29-64), amide, human acetate is able to protect cortical neurons from Aβ25-35?toxicity. 2 μM NPY abolishes the toxic effects of Aβ25-35?at 24 and 48 h. The same effect on neuronal survival is observed in neurons exposed to 1 μM and 0.5 μM Neuropeptide Y (29-64), amide, human acetate pretreatments. Pretreatment with Neuropeptide Y (29-64), amide, human acetate Increases NGF Synthesis, reduces NGF mRNA, and restores NGF release in cortical neurons exposed to Aβ35-25[1]. |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Keywords | Neuropeptide Y (2964), amide, human acetate | Neuropeptide Y (29 64), amide, human acetate | Neuropeptide Y , amide, human Acetate |
Inhibitors Related | HT-2157 | L 152804 | GW438014A | Peptide YY (PYY) (3-36), human | Selvigaltin | SF-22 | JNJ-31020028 | DF-1012 FA | AR-M 1896 Acetate | AC-099 hydrochloride |
Related Compound Libraries | Peptide Compound Library |